[On Demand]
Owkin is a biotech startup in NYC that applies artificial intelligence (AI) and deep learning to build predictive models by integrating pathology, imaging, NGS and EHR data to predict prognosis, survival, treatment response and discover biomarkers for oncology, cardiovascular and COVID-19. We work closely with academic centers/PIs to develop breakthrough research projects and access valuable medical data. The data will never leave the institutional firewall, only the trained model will.

Owkin has developed a novel federated learning system, where large scale data from multiple research institutes can be used to develop a global federated model, overcoming sharing problems related with medical data and allows to build collective intelligence from distributed data at scale while preserving privacy and security. Owkin licenses these models to pharmaceutical companies, where partner institutes will receive royalties. We have developed 70+ models and published 20+ papers in top journals.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Federated Models in multiple cancers
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Partnership Manager